361 related articles for article (PubMed ID: 30550845)
1. Geraniol protects against lipopolysaccharide and D-galactosamine-induced fulminant hepatic failure by activating PPARγ.
Li Y; Wang N; Jiang Y
Microb Pathog; 2019 Mar; 128():7-12. PubMed ID: 30550845
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.
Liu H; Zhang W; Dong S; Song L; Zhao S; Wu C; Wang X; Liu F; Xie J; Wang J; Wang Y
J Ethnopharmacol; 2015 Dec; 176():69-78. PubMed ID: 26494508
[TBL] [Abstract][Full Text] [Related]
3. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747
[TBL] [Abstract][Full Text] [Related]
4. Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway.
Pan CW; Yang SX; Pan ZZ; Zheng B; Wang JZ; Lu GR; Xue ZX; Xu CL
Oncotarget; 2017 Jun; 8(25):41202-41210. PubMed ID: 28465482
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of tenuigenin on lipopolysaccharide and d-galactosamine-induced acute liver injury.
Jia R; Zhang H; Zhang W; Zhao H; Zha C; Liu Y
Microb Pathog; 2017 Nov; 112():83-88. PubMed ID: 28958948
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the crosstalk between Keap1/Nrf2/HO-1 and NF-κB signaling pathways by Tomatidine protects against inflammation/oxidative stress-driven fulminant hepatic failure in mice.
Abdulaal WH; Omar UM; Zeyadi M; El-Agamy DS; Alhakamy NA; Ibrahim SRM; Almalki NAR; Asfour HZ; Al-Rabia MW; Mohamed GA; Elshal M
Int Immunopharmacol; 2024 Mar; 130():111732. PubMed ID: 38402834
[TBL] [Abstract][Full Text] [Related]
7. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E
Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073
[TBL] [Abstract][Full Text] [Related]
8. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway.
Tao YC; Wang ML; Wu DB; Luo C; Tang H; Chen EQ
J Transl Med; 2019 May; 17(1):151. PubMed ID: 31077206
[TBL] [Abstract][Full Text] [Related]
10. Synthetic RGDS peptide attenuated lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice.
Yin X; Gong X; Jiang R; Zhang L; Wang B; Xu G; Wang C; Wan J
J Gastroenterol Hepatol; 2014 Jun; 29(6):1308-15. PubMed ID: 24476051
[TBL] [Abstract][Full Text] [Related]
11. CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice.
Yan L; Hu X; Wu Q; Jiang R; Zhang S; Ling Q; Liu H; Jiang X; Wan J; Liu Y
Int Immunopharmacol; 2017 Jun; 47():231-243. PubMed ID: 28433945
[TBL] [Abstract][Full Text] [Related]
12. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Jin Q; Jiang S; Wu YL; Bai T; Yang Y; Jin X; Lian LH; Nan JX
Phytomedicine; 2014 Jan; 21(2):141-7. PubMed ID: 24011530
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1.
Kim SJ; Lee SM
Free Radic Biol Med; 2013 Dec; 65():997-1004. PubMed ID: 23994575
[TBL] [Abstract][Full Text] [Related]
14. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
Fu T; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
Biomed Pharmacother; 2018 Oct; 106():896-901. PubMed ID: 30119260
[TBL] [Abstract][Full Text] [Related]
15. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y
Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.
Xie C; Jingjing W; Li X; Zeng F; Ma L; Li C; Wei Z; Peng A; Chen L
Int Immunopharmacol; 2014 Aug; 21(2):261-8. PubMed ID: 24861250
[TBL] [Abstract][Full Text] [Related]
17. Ellagic acid protects Lipopolysaccharide/D-galactosamine-induced acute hepatic injury in mice.
Gu L; Deng WS; Liu Y; Jiang CH; Sun LC; Sun XF; Xu Q; Zhou H
Int Immunopharmacol; 2014 Oct; 22(2):341-5. PubMed ID: 25038320
[TBL] [Abstract][Full Text] [Related]
18. Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-κB, and the induction of autophagy.
Lv H; Fan X; Wang L; Feng H; Ci X
Int J Biol Macromol; 2018 Nov; 119():240-248. PubMed ID: 30031824
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of alpinetin on lipopolysaccharide/d-Galactosamine-induced liver injury through inhibiting inflammatory and oxidative responses.
Liu TG; Sha KH; Zhang LG; Liu XX; Yang F; Cheng JY
Microb Pathog; 2019 Jan; 126():239-244. PubMed ID: 30414839
[TBL] [Abstract][Full Text] [Related]
20. Saikosaponin a ameliorates lipopolysaccharide and d‑galactosamine-induced liver injury via activating LXRα.
Zhu Y; Chen X; Rao X; Zheng C; Peng X
Int Immunopharmacol; 2019 Jul; 72():131-137. PubMed ID: 30981078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
